COMMUNIQUÉS West-GlobeNewswire

Journée mondiale de l’alimentation : Québec doit reconnaître le droit à l’alimentation

16/10/2024 - 16:10

MONTRÉAL, 16 oct. 2024 (GLOBE NEWSWIRE) -- En cette Journée mondiale de l’alimentation, le Collectif Vital , qui réunit les appuis de 740 partenaires, souhaite joindre sa voix à la mobilisation pour la reconnaissance du [...]

Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®

16/10/2024 - 16:00

ST. LOUIS, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Optime Care, a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded arrangement with Rigel Pharmaceuticals, Inc , effective [...]

SCALE Healthcare Honors USOSM’s Richard Hall for Excellence

16/10/2024 - 15:41

IRVING, Texas, Oct. 16, 2024 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) President and CEO Richard Hall recently received the SCALE Community MSO Excellence Award, which recognizes excellence in healthcare [...]

Renovaro Announces Strategic Restructuring and Leadership Transition

16/10/2024 - 15:28

Supermajority of Shareholders Support Appointment of New CEO and the Replacement of Entire Board of Directors with Full Five-Member Slate Realignment of Resources to Optimize and Commercialize RenovaroCube, the Company’ [...]

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

16/10/2024 - 15:20

During the Phase 1 study, subjects utilized EEG headsets provided by Firefly partner, Zeto, after which the data was analyzed using Firefly’s advanced AI BNA technology analysis platform TORONTO, Oct. 16, 2024 (GLOBE [...]

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

16/10/2024 - 15:15

HOUSTON, Oct. 16, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of [...]

Cepham Prioritizes Women’s Health to Address Research and Innovation Gender Gap

16/10/2024 - 15:00

SOMERSET, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Cepham , a leader in nutraceutical research and development, is taking strategic steps to bridge the gender gap in health research and innovation, with a focus on women’ [...]

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design

16/10/2024 - 15:00

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design Concept 2024 in the [...]

Biomerica Reports First Quarter Fiscal 2025 Financial Results

16/10/2024 - 15:00

Total Revenue Increases 6% Over Same Period Last Year Cost-Saving Measures Now Implemented, Expected to Reduce Annual Expenses by 16% to 23%, Representing $1.0 to $1.4 Million Reduction Biomerica's At-Home PSA Screening [...]

Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access

16/10/2024 - 15:00

SALT LAKE CITY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a strategic partnership with jscreen™, a national organization [...]

First Stop Health Launches New Whole Mental Health Program

16/10/2024 - 15:00

New offering will help businesses address the full spectrum of employee mental and physical health needs with a unique model that includes guaranteed usage and 100% fees at risk CHICAGO, Oct. 16, 2024 (GLOBE NEWSWIRE [...]

KYZATREX® (testosterone undecanoate) CIII Capsules Featured in Research at the Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting

16/10/2024 - 15:00

RALEIGH, N.C., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals is pleased to announce that KYZATREX ® (testosterone undecanoate) CIII capsules will be highlighted in three research abstracts at the upcoming [...]

GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621’s Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)

16/10/2024 - 14:45

Data suggest that NKT cells are activated in airways in Idiopathic Pulmonary Fibrosis (IPF) patients and inhibition of iNKT cell activity can treat bleomycin-induced pulmonary fibrosis Company advancing Phase 2a [...]

Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress

16/10/2024 - 14:30

MIAMI, FL, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, [...]

Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024

16/10/2024 - 14:30

BRISBANE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for [...]

Elicio Therapeutics Reports Inducement Grants

16/10/2024 - 14:30

BOSTON, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the [...]

Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency

16/10/2024 - 14:30

Achieved proof-of-mechanism for Wave’s RNA editing platform; restoring levels of wild-type (edited) M-AAT that are consistent with the heterozygous “MZ” genotype with low risk of AATD lung and liver disease A single [...]

Wave Life Sciences Announces Upcoming Virtual Research Day on Wednesday, October 30, 2024

16/10/2024 - 14:25

Event will highlight WVE-006 for AATD and Wave’s rapidly advancing, wholly owned pipeline of RNA medicines, including introducing new RNA editing programs and new preclinical data for WVE-007 INHBE program for obesity [...]

23andMe Announces Completion of 1-for-20 Reverse Stock Split

16/10/2024 - 14:15

SUNNYVALE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), announced today the completion of the previously announced 1-for-20 reverse stock split of the Company’ [...]